CEMI News and Press, Chembio Diagnostics Inc. From 11/03/22

HAUPPAUGE, N.Y., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (“Chembio” or the “Company”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended September ...

HAUPPAUGE, N.Y., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the third quarter of 2022 after the close of trading on Thursda...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: oneinchpunch/Shutterstock.com Get ready for one more day of trading this week with the biggest pre-market stock movers for Friday! Moving stocks this morning are merger agreements, stock offerings, reports o...

Chembio Diagnostics ( NASDAQ: CEMI ) said it was awarded a $3.2M contract from the Centers for Disease Control and Prevention (CDC) to develop and validate a rapid point-of-care (POC) diagnostic test for syphilis. Chembio will develop a syphilis test and confirm a...

HAUPPAUGE, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced it was awarded a $3.2 million contract from the Centers for Disease Control and Prevention...

3 Trending Penny Stocks to Add to Your Watchlist Right Now When it comes to investing in penny stocks, there are a lot of ups and downs. In a volatile market, penny stocks can be a great investment. However, you need to know what you’re doing in order to make money off of them. T...

Chembio Diagnostics ( NASDAQ: CEMI ) said it is evaluating the potential to develop a monkeypox rapid point-of-care (POC) test. The company added that it is exploring the technical requirements for test development using its technology platforms, DPP, SURE CHECK, and S...

HAUPPAUGE, N.Y., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced it is evaluating the potential to develop a monkeypox rapid point-of-care (POC) test. Chemb...

NuZee ( NUZE ) -24% on pricing $3.4M stock offering . Reata Pharmaceuticals ( RETA ) -20% on Q2 earnings release . Palantir Technologies ( PLTR ) -14% on Q2 earnings release . Digital World Acquisition ( DWACW ) -10% . Cognit...

Chembio Diagnostics, Inc. (CEMI) Q2 2022 Earnings Conference Call August 4, 2022, 4:30 PM ET Company Participants Philip Taylor - Investor Relations Rick Eberly - President and CEO Larry Steenvoorden - Chief Financial Officer Conference Call Participants ...